Both in Surgical Instruments
SpyGlass Pharma vs SI-BONE
Over the past year SGP returned −3.6% and SIBN returned +22.8%; their daily moves had a correlation of 0.21.
SGP −3.6% SIBN +22.8%Growth of $1, one year, split-adjusted
| Metric | SGP | SIBN |
|---|---|---|
| Price | $25.44 | $19.15 |
| Market cap | $850.9M | $858.3M |
| Today | −2.08% | +2.08% |
| 1 month | −3.7% | −0.3% |
| 6 months | +8.9% | +55.9% |
| Year to date | — | −2.9% |
| 1 year | — | +36.3% |
| Revenue growth (YoY) | — | +15.2% |
| Gross margin | — | 79.5% |
| Net margin | — | −7.3% |
| P/E (TTM) | — | — |
| Price / sales | — | 4.0× |
| Net cash | $234.2M | $110.3M |
| Dividend yield | — | — |
| Volatility (60d) | 53.0% | 31.2% |
| Short % of float | 20.7% | 13.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).